Quest will offer the first FDA-approved blood test to help detect Alzheimer’s-related amyloid pathology in patients with ...

Quest Diagnostics to offer US FDA-approved Fujirebio blood test for Alzheimer's disease: Secaucus, New Jersey Friday, July 11, 2025, 14:00 Hrs [IST] Quest Diagnostics, a leader in ...

Dr. Ho Sang Jung and his research team from the Advanced Bio and Healthcare Materials Research Division at the Korea ...

An alternative diagnostic method could improve early detection and treatment of peripheral artery disease (PAD), according to ...

Blood proteomics is the study of proteins in blood plasma and is used in everything from cancer treatments to identifying ...

Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, including advanced diagnostics for brain health, today announced it plans to offer laboratory testing based on the ...

After decades of research, the U.S. Food and Drug Administration (FDA) has approved a test that can detect the buildup of amyloid plaques in the brain—a key marker of Alzheimer’s disease, ...

Are biological age tests worth the hype? Direct-to-consumer biological age tests promise insights into how your body is aging, but experts say they should be taken with caution.

The U.S. Sixth Circuit Court of Appeals has ruled the state of Michigan does not have to destroy data gleaned from infant blood samples collected by hospitals at birth.

Up-and-coming Alzheimer’s blood tests may soon be used for people with Down’s syndrome. In a longitudinal biomarker study of adults with three copies of chromosome 21, investigators from the Alzheimer ...